TY - JOUR
T1 - Comorbidity
T2 - A multidimensional approach
AU - Capobianco, Enrico
AU - Lio', Pietro
N1 - Funding Information:
E.C. acknowledges the support from the Center for Computational Science (University of Miami) and IFC-CNR (Pisa) and P.L. is supported by EC FP7 COLLABORATIVE PROJECT Mission T2D. Both authors gratefully acknowledge exchange and receipt of useful discussion and feedback from Marc Lippman (Cancer Center) and Nick Tsinoremas (CCS and Faculty of Medicine) at the University of Miami. Special thanks go to Maria Giovanna Trivella (IFC-CNR, Pisa, cardiology unit) who enthusiastically agreed to participate in our discussions, and helped our understanding of clinical aspects and patient care.
PY - 2013/9
Y1 - 2013/9
N2 - Comorbidity represents an extremely complex domain of research. An individual entity, the patient, is the center of gravity of a system characterized by multiple, complex, and interrelated conditions, disorders, or diseases. Such complexity is influenced by uncertainty that is difficult to decipher and is proportional to the number of associated morbidities. Computational scientists usually provide meta-analysis studies aimed at integrating various types of evidence, but in our opinion they may help reformulate comorbidity by emphasizing, in particular, two aspects: (i) a systems approach, which allows for an ensemble view of comorbidity, and offers a model representation generalizable to multimorbidity; and (ii) a dynamic network inference approach, which is indicated for the analysis of links among morbidities and evaluation of risk. Notably, the main question remains whether such instruments suggest a shift of paradigm providing prospective impact on medical practice. We have identified in the simultaneous consideration of multiple dimensions linked to comorbidity complexity the rationale for such translation.
AB - Comorbidity represents an extremely complex domain of research. An individual entity, the patient, is the center of gravity of a system characterized by multiple, complex, and interrelated conditions, disorders, or diseases. Such complexity is influenced by uncertainty that is difficult to decipher and is proportional to the number of associated morbidities. Computational scientists usually provide meta-analysis studies aimed at integrating various types of evidence, but in our opinion they may help reformulate comorbidity by emphasizing, in particular, two aspects: (i) a systems approach, which allows for an ensemble view of comorbidity, and offers a model representation generalizable to multimorbidity; and (ii) a dynamic network inference approach, which is indicated for the analysis of links among morbidities and evaluation of risk. Notably, the main question remains whether such instruments suggest a shift of paradigm providing prospective impact on medical practice. We have identified in the simultaneous consideration of multiple dimensions linked to comorbidity complexity the rationale for such translation.
KW - Clustering
KW - Comorbidity
KW - Dynamic mapping
KW - Inference
KW - Multidimensionality
KW - Patient disease network
UR - http://www.scopus.com/inward/record.url?scp=84883822001&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883822001&partnerID=8YFLogxK
U2 - 10.1016/j.molmed.2013.07.004
DO - 10.1016/j.molmed.2013.07.004
M3 - Review article
C2 - 23948386
AN - SCOPUS:84883822001
VL - 19
SP - 515
EP - 521
JO - Trends in Molecular Medicine
JF - Trends in Molecular Medicine
SN - 1471-4914
IS - 9
ER -